Difficulty: Medium
Average Score: 75%
Practice
Which of the following oral hypoglycaemic drugs stimulates both synthesis and release of insulin from beta islet cells:
Correct answer
A
Rationale
The correct answer is A) Glibenclamide. Glibenclamide belongs to the sulfonylurea class of oral hypoglycemic drugs, which work by stimulating both the synthesis and release of insulin from beta islet cells in the pancreas. This increase in insulin helps to lower blood glucose levels in individuals with diabetes.
Option B) Phenformin is incorrect because it belongs to the biguanide class of drugs and works by decreasing the production of glucose in the liver and improving insulin sensitivity in peripheral tissues, but it does not directly stimulate insulin release from beta cells.
Option C) Buformin is also a biguanide like phenformin and works similarly by decreasing hepatic glucose production and improving insulin sensitivity, but it does not directly stimulate insulin release.
Option D) Metformin is another biguanide drug that primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It does not directly stimulate insulin release from beta islet cells.
In an educational context, understanding how different classes of oral hypoglycemic drugs work is essential for healthcare professionals managing patients with diabetes. Knowing the mechanisms of action of these drugs helps in making informed decisions about treatment options based on individual patient needs and characteristics. It also underscores the importance of proper medication selection to achieve optimal glycemic control while minimizing side effects and complications associated with diabetes management.
Option B) Phenformin is incorrect because it belongs to the biguanide class of drugs and works by decreasing the production of glucose in the liver and improving insulin sensitivity in peripheral tissues, but it does not directly stimulate insulin release from beta cells.
Option C) Buformin is also a biguanide like phenformin and works similarly by decreasing hepatic glucose production and improving insulin sensitivity, but it does not directly stimulate insulin release.
Option D) Metformin is another biguanide drug that primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. It does not directly stimulate insulin release from beta islet cells.
In an educational context, understanding how different classes of oral hypoglycemic drugs work is essential for healthcare professionals managing patients with diabetes. Knowing the mechanisms of action of these drugs helps in making informed decisions about treatment options based on individual patient needs and characteristics. It also underscores the importance of proper medication selection to achieve optimal glycemic control while minimizing side effects and complications associated with diabetes management.